1. Salivary Fusobacterium nucleatum serves as a potential diagnostic biomarker for gastric cancer
   Wen-Dan Chen et al, 2022, World Journal of Gastroenterology CrossRef
2. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression
   Biqiang Zhu et al, 2023, Chinese Medical Journal CrossRef
3. l-Fucose increases the fucosylation of colorectal cancer cells via promoting the accumulation of serine
   Ye Yao et al, 2023, Food & Function CrossRef
4. Research progress on the functions, preparation and detection methods of l-fucose
   Yan Wang et al, 2024, Food Chemistry CrossRef
5. The role of gut microbiota and metabolites in cancer chemotherapy
   Shiyu Li et al, 2024, Journal of Advanced Research CrossRef
6. About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview
   Luca Ciani et al, 2024, International Journal of Molecular Sciences CrossRef
7. Targeting the gut microbiota: a new strategy for colorectal cancer treatment
   Yue Hu et al, 2024, Journal of Translational Medicine CrossRef
8. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
   Suwen Ou et al, 2022, Frontiers in Cellular and Infection Microbiology CrossRef
9. Microbial Synthesis of l-Fucose with High Productivity by a Metabolically Engineered Escherichia coli
   Jiawei Meng et al, 2023, Journal of Agricultural and Food Chemistry CrossRef
10. Potential role of epithelial–mesenchymal transition induced by periodontal pathogens in oral cancer
    Yiwei Ma et al, 2024, Journal of Cellular and Molecular Medicine CrossRef